Table 1.
Year of publication | Sex | Age | Duration of symptoms at admission | Papilledema | Bb IgM CSF | Bb IgG CSF |
Bb IgG CSF/serum‐ratio |
Pleocytosis (leukocytes) |
CSF‐protein |
Opening pressure |
Antibiotic treatment | Other treatment | Sequelae |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
19861 | Not reported | >32 y | Not reported |
Bilateral (fundoscopy) |
Positive | Positive | Elevated. | Not reported | Not reported | 420 mm H2O | Iv Penicillin, 2 MIE for 10 d | Not reported | atrophy of optic nerve. |
20033 | Male | 37 y | 5 wk | Not present (fundoscopy) | Positive | Positive | Elevated. |
1 U/mm3 (after 3 wk of treatment) |
Normal |
Could not be measured. CSF was shot through the room |
P.o. Doxycycline 100 mg. ×2 daily in 3 wk | 2 wk after three therapeutic lumbal punctures with 4 and 6 d in between | None. |
20032 | Female | 19 y | 8 wk (2 mo) |
Bilateral (fundoscopy) |
Not reported | Positive | 1.1 | Not reported | Not reported | 300 mm H2O | Iv 2 g Ceftriaxone for 2 wk | None. | None. |
20084 | Male | 34 y | Almost a week (6 d) |
Bilateral (fundoscopy) |
Positive | Negative | Not reported | 6 U/mm3 | 100 mg/dL | 260 mm H2O | Iv 2 g. Ceftriaxone for 4 weeks | None | None |
20165 | Male | 20 y | 1 wk |
Bilateral (fundoscopy) |
Positive | Negative | Not reported | 14 U/mm3 | 37 mg/dL (normal) | 400 mm H2O | Iv 2 g. Ceftriaxone for 4 wk | Acetazolamide | None. |
2017 (The case described in this article) |
Female | 51 y | 78 wk (1.5 y) |
Bilateral (fundoscopy and MRI) |
Negative | Positive | 2.36 | 77 U/mm3 | 300 mg./dL | 500 mm H2O | Iv 2 g. Ceftriaxone for 18 d |
Acetazolamide 1 wk, 4 therapeutic LBP, VP‐shunt |
On one eye papilla optica atrophy, loss of color vision, and a central scotoma. |
Abbreviation: Bb, Borrelia burgdorferi.